Tharos Ltd is a UK-based startup that aims to improve the health and welfare of animals by aiding in the maintenance of an optimised microbiome. The company, founded in 2016, focuses on digestive health, the gut microbiome, and colonic malfermentation in horses. Tharos is committed to promoting equine health and increased well-being through research, discovery, and innovation, harnessing the potential of both science and nature. Their product EQUINECTAR®, developed after four years of groundbreaking research with Cumani Racing and others, is a pioneering solution for digestive issues in performance horses. As a member of the British Equestrian Trade Association (BETA), Tharos presents a compelling opportunity to horse professionals worldwide. The startup operates in the Biotechnology, Health Care, and Sports industries. Tharos received a Seed Round investment on 08 February 2019.
General Information
Get notified when Tharos Ltd moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Tharos Ltd
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United Kingdom Market
Biotechnology
About Tharos Ltd
Taxonomy: Equine Health, Digestive Health, Gut Microbiome, Veterinary Research, Animal Welfare, Performance Analysis, Innovation, Feed Supply, Equine Nutrition
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | - | 08 Feb 2019 |
Tharos Ltd Alternatives & Competitors
The Worlds First Artificial Intelligence Platform to promote Equine Welfare
Empowering equine performance through science-based supplements since 1975
Equine-Assisted Mental Health Treatment and Research; Equine-Assisted Counseling & Activities for St...
FAQ About Tharos Ltd
Don't just browse. Track.
Signal Tracker monitors Tharos Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.